Mixed Connective Tissue Disease and Papillary Thyroid Cancer: A Case Report.

Authors:
Supat Thongpooswan
Supat Thongpooswan
Queens Hospital Center
United States
Rachel Tushabe
Rachel Tushabe
Icahn School of Medicine at Mount Sinai Service
Paul Kim
Paul Kim
University of Southern California
United States
Adriana Abrudescu
Adriana Abrudescu
Icahn School of Medicine at Mount Sinai

Am J Case Rep 2015 Aug 6;16:517-9. Epub 2015 Aug 6.

Department of Internal Medicine, Icahn School of Medicine at Mount Sinai Service, Queens Hospital Center, Jamaica, NY, USA.

Background: Mixed connective tissue disease (MCTD) is a connective tissue disorder characterized by high titers of distinct antibodies: U1 ribonucleoprotein with clinical features seen in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), dermatomyositis (DM), polymyositis, and scleroderma. The association of SLE and DM with various cancers of the thyroid has been reported in the literature. However, there have been no reports associating MCTD with thyroid cancer.

Case Report: We present a 58-year-old woman diagnosed with MCTD with co-morbid interstitial lung disease that has remained stable for 10 years, who developed papillary thyroid carcinoma (PTC) 10 years after initial diagnosis.

Conclusions: We theorize that: 1) MCTD may have been a primary diagnosis complicated by PTC, or 2) MCTD may have been an initial presentation of paraneoplastic syndrome of silent PTC, because her symptoms of MCTD significantly improved after total thyroidectomy. To the best of our knowledge, this is the first case report to associate MCTD with PTC. It highlights the importance of maintaining a high index of suspicion for thyroid malignancy in MCTD patients.

Download full-text PDF

Source
http://dx.doi.org/10.12659/AJCR.894176DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530986PMC
August 2015
3 Reads

Publication Analysis

Top Keywords

connective tissue
12
papillary thyroid
8
mctd
8
tissue disease
8
case report
8
mixed connective
8
thyroid
5
58-year-old woman
4
report 58-year-old
4
cancercase report
4
mctd improved
4
thyroid cancercase
4
diagnosed mctd
4
co-morbid interstitial
4
ptc symptoms
4
symptoms mctd
4
mctd co-morbid
4
improved total
4
woman diagnosed
4
mctd thyroid
4

Similar Publications

[Clinical features and laboratory findings in children with both anti-dsDNA and anti-U1-RNP antibody].

Nihon Rinsho Meneki Gakkai Kaishi 2008 Oct;31(5):405-14

Department of Pediatrics, Yokohama City University.

Mixed connective tissue disease (MCTD) includes clinical features of systemic lupus erythematosus (SLE), dermatomyositis/polymyositis (DM/PM), and systemic sclerosis (SSc) occurring in conjunction with a high anti-U1-RNP antibody titer. Childhood MCTD rarely manifests the symptoms and signs of DM/PM and SSc, and mostly does those of SLE. Thus, the diagnosis of childhood MCTD is inevitably based on the two major findings, Raynaud's phenomenon and a high titer of anti-U1-RNP antibody. Read More

View Article
October 2008

Association of systemic and thyroid autoimmune diseases.

Clin Rheumatol 2006 Mar 25;25(2):240-5. Epub 2005 Oct 25.

3rd Department of Medicine, University of Debrecen Medical and Health Sciences Center, 22 Moricz street, 4004 Debrecen, Hungary.

Objective: There are few large cohort studies available on the association of systemic and thyroid autoimmune diseases. In this study, we wished to determine the association of Hashimoto's thyroiditis (HT) and Graves' disease (GD) with systemic autoimmune diseases.

Methods: One thousand five hundred and seventeen patients with systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), mixed connective tissue disease (MCTD), Sjögren's syndrome (SS) and polymyositis/dermatomyositis (PM/DM) were included in the study. Read More

View Article
March 2006

Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients.

J Rheumatol 1989 Mar;16(3):328-34

Department of Immunology and Rheumatology, Instituto Nacional de la Nutrición Salvador Zubirán, Mexico City, Mexico.

We tested patients with a well defined connective tissue disease (CTD) against 3 different sets of criteria for mixed connective tissue disease (MCTD). Included were 200 patients with systemic lupus erythematosus (SLE), 80 with MCTD, 100 with rheumatoid arthritis (RA), 80 with scleroderma, 53 with dermato/polymyositis (DM/PM) and 80 with primary Sjögren's syndrome (SS). The 3 sets of criteria fared similarly in capturing nearly all MCTD patients. Read More

View Article
March 1989

Association of HLA-DRB1 alleles with susceptibility to mixed connective tissue disease in Polish patients.

HLA 2016 Jan 9;87(1):13-8. Epub 2015 Nov 9.

Department of Biochemistry and Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.

Mixed connective tissue disease (MCTD) is a systemic autoimmune disease, originally defined as a connective tissue inflammatory syndrome with overlapping features of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), polymyositis/dermatomyositis (PM/DM) and systemic sclerosis (SSc), characterized by the presence of antibodies against components of the U1 small nuclear ribonucleoprotein (U1snRNP). The aim of the study was to assess the frequency of (high-resolution-typed) DRB1 alleles in a cohort of Polish patients with MCTD (n = 103). Identification of the variants potentially associated with risk and protection was carried out by comparison with the DKMS Polish Bone Marrow Donor Registry (41306 alleles). Read More

View Article
January 2016